Giovanni Guidotti
Biographic Data
| ID | 9998421 |
|---|---|
| NAME | Giovanni Guidotti |
| GIVEN NAMES | Giovanni |
| FAMILY NAME | Guidotti |
| SIGNATURE | GUIDOTTI G |
| AFFILIATIONS | ASL Roma |
| ORCID | 0000-0002-8462-2901 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Maintain, not obtain
Over the past four decades, the HIV epidemic in sub-Saharan Africa has shifted from an acute, high-mortality phase to an era of widespread antiretroviral therapy (ART), driven by global scale up and the introduction of potent regimens such as dolutegravir-based combinations. While viral suppression is now increasingly achievable, the central challenge has evolved toward maintaining durable virological control across the life course. We argue that…
The warning bell of Dolutegravir resistance
The emergence of resistance to Dolutegravir (DTG)—the cornerstone of first-line antiretroviral therapy—marks a critical turning point in the fight against HIV in Africa. Once considered unlikely due to DTG’s high genetic barrier, resistance is now increasingly reported, raising urgent questions about current HIV service models. This Perspective argues that the spread of resistance must be seen not only as a clinical threat but as a warning signal…
Hypertension outcomes in a fragile setting
Background Hypertension is a leading contributor to cardiovascular disease and early mortality, and its impact is growing rapidly in low-income countries. In the Central African Republic, the condition represents a major and under-addressed health problem. This study examines the outcomes of hypertension care in Bangui, focusing on factors influencing blood pressure control and reduction (CAR). Methods This cross-sectional study analyzed clinical…
No prominent works on this page.
The warning bell of Dolutegravir resistance
The emergence of resistance to Dolutegravir (DTG)—the cornerstone of first-line antiretroviral therapy—marks a critical turning point in the fight against HIV in Africa. Once considered unlikely due to DTG’s high genetic barrier, resistance is now increasingly reported, raising urgent questions about current HIV service models. This Perspective argues that the spread of resistance must be seen not only as a clinical threat but as a warning signal…
Hypertension outcomes in a fragile setting
Background Hypertension is a leading contributor to cardiovascular disease and early mortality, and its impact is growing rapidly in low-income countries. In the Central African Republic, the condition represents a major and under-addressed health problem. This study examines the outcomes of hypertension care in Bangui, focusing on factors influencing blood pressure control and reduction (CAR). Methods This cross-sectional study analyzed clinical…
Maintain, not obtain
Over the past four decades, the HIV epidemic in sub-Saharan Africa has shifted from an acute, high-mortality phase to an era of widespread antiretroviral therapy (ART), driven by global scale up and the introduction of potent regimens such as dolutegravir-based combinations. While viral suppression is now increasingly achievable, the central challenge has evolved toward maintaining durable virological control across the life course. We argue that…
Dolutegravir (2 works) · HIV/AIDS Research and Interventions (2 works) · Antiretroviral therapy (1 work) · Blood pressure (1 work) · Blood Pressure and Hypertension Studies (1 work) · Call to action (1 work) · Case-control study (1 work) · Cornerstone (1 work) · Diabetes mellitus (1 work) · Drug resistance (1 work)